CLOCK and prostate carcinoma: The clock–cancer connection in prostate cancer and circadian-related therapies provide a potential novel opportunity to mitigate racial disparities in prostate cancer risk, progression, and treatment outcomes through the optimization of current treatment modalities and reduction in therapeutic resistance.